NCT00229632 - Idebenone to Treat Friedreich's Ataxia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 27, 2005

Primary Completion Date

December 17, 2007

Study Completion Date

December 17, 2007

Conditions

Friedreich Ataxia

Interventions

DRUG

Idebenone

Idebenone is a short-chain benzoquinone derivative of similar structure to ubiquinone (coenzyme Q10). This compound was synthesized and developed initially by Takeda Chemical Industries, Ltd. (Osaka, Japan) and designated as CV-2619. The chemical name for idebenone is 6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benxoquinone. Santhera Pharmaceuticals (Liestal, Switzerland) LLC, will supply drug for this study as specified by a clinical trial agreement.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH